Fei Tang

Fei Tang is a Principal Scientist at Cellular Biomedicine Group, focusing on CAR T-cell therapy and engineered TCR T-cell therapy. Prior to this, Fei was a Research Faculty at the University of Maryland School of Medicine, where Fei worked on projects involving CAR-T cells and screening anti-CTLA-4 mAbs. Tang has a Ph.D. in Biochemistry and Molecular Biology from the Graduate School of the Chinese Academy of Sciences.